These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2439801)

  • 1. Beta 1/beta 2-splitting of bisoprolol.
    Dorow P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S65-8. PubMed ID: 2439801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.
    Dorow P; Tönnesmann U
    Eur J Clin Pharmacol; 1984; 27(2):135-9. PubMed ID: 6149938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].
    Prager G; Wagner G
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1914-7. PubMed ID: 6150839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.
    Lammers JW; Folgering HT; van Herwaarden CL
    Eur J Clin Pharmacol; 1984; 27(2):141-5. PubMed ID: 6149939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of atenolol in chronic pulmonary patients with airway obstruction].
    Vancrombreucq JC; Schandevyl W
    Lille Med; 1978; 23(7):506-12. PubMed ID: 31524
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effects of nifedipine on patients with chronic obstructive lung disease.
    Ikeda H; Takahashi K; Sasaki H; Ito E; Yasui S
    Arzneimittelforschung; 1985; 35(2):518-21. PubMed ID: 4039574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
    Giorgis GE; Galietti F; Miravalle C; Barberis S; Massaglia GM; Onoscuri E
    Minerva Med; 1986 Jun; 77(26):1255-8. PubMed ID: 2873530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 16. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
    Wagner G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisoprolol in the treatment of chronic stable angina pectoris.
    Terol I; Plaza L; Rodrigo F
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bisoprolol on cardiac performance in coronary heart disease.
    Maisch B; Borst U; Gerhards W; Wagner G
    Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.